Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists develop cancer-fighting robots
Magnified algae with magnetic coating.

Devices pave way for the development of new treatments

Scientists have developed tiny, remote-controlled robots that release cancer-fighting compounds. It is hoped that the robots may someday be used to diagnose and treat illness in areas of the human body that are difficult to reach.

Developed by an international team of researchers, the ‘micro-robots’ are coated in microscopic algae with non-harmful, biocompatible magnetic particles. The devices are about the size of a blood cell and can swim in biological fluids, such as dilute blood and gastric fluid.

In experiments with rats, scientists used magnets to guide the robots to sites in the stomach. They could be tracked in tissue close to the surface of the skin by imaging the algae’s natural luminescence. In harder-to-reach tissue, they could be tracked using an MRI scanner.

Besides delivering drugs to areas of the body that are hard-to-reach, scientists say the robots could also sense chemical changes linked to the onset of illness. This could one day make them useful as probes for remote diagnosis.

The devices biodegrade within the body and can take more or less time depending on the thickness of their manufactured coating.
Qi Zhou, of the University of Edinburgh’s School of Engineering, who worked on the study, said:

“A small-scale robot that can be remotely guided, is easily tracked and harmlessly biodegrades, potentially overcomes many of the challenges faced by minimally invasive therapies. We hope our discoveries will pave the way for the development of useful diagnostics or treatments.”

The study, published in Science Robotics, was carried out in collaboration with the Universities of Edinburgh and Manchester.

Image (C) Yan et al Science Robotics 2017.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.